Home > Insider Trading > Filing (0000950170-23-064799)

Filing Details

Accession Number:: 0000950170-23-064799
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-11-17 16:05:32
Reporting Period:: 2023-11-15

Accepted Time:: 2023-11-17 16:05:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1773383	Dynatrace Inc.	DT	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1537211	Thoma Bravo Fund X, L.p.	C/O Thoma Bravo, L.p. 110 N. Wacker Drive, 32Nd Floor Chicago IL 60606	No	No	No	No
1537212	Thoma Bravo Fund X-A, L.p.	C/O Thoma Bravo, L.p. 110 N. Wacker Drive, 32Nd Floor Chicago IL 60606	No	No	No	No
1579904	Thoma Bravo Special Opportunities Fund I, L.p.	C/O Thoma Bravo, L.p. 110 N. Wacker Drive, 32Nd Floor Chicago IL 60606	No	No	No	No
1606286	Thoma Bravo Fund Xi, L.p.	C/O Thoma Bravo, L.p. 110 N. Wacker Drive, 32Nd Floor Chicago IL 60606	No	No	No	No
1606287	Thoma Bravo Fund Xi-A, L.p.	C/O Thoma Bravo, L.p. 110 N. Wacker Drive, 32Nd Floor Chicago IL 60606	No	No	No	No
1606288	Thoma Bravo Executive Fund Xi, L.p.	C/O Thoma Bravo, L.p. 110 N. Wacker Drive, 32Nd Floor Chicago IL 60606	No	No	No	No
1722232	Thoma Bravo Partners Xi, L.p.	C/O Thoma Bravo, L.p. 110 N. Wacker Drive, 32Nd Floor Chicago IL 60606	No	No	No	No
1783009	Thoma Bravo Partners X, L.p.	C/O Thoma Bravo, L.p. 110 N. Wacker Drive, 32Nd Floor Chicago IL 60606	No	No	No	No
1783011	Thoma Bravo Special Opportunities Fund I Aiv, L.p.	C/O Thoma Bravo, L.p. 110 N. Wacker Drive, 32Nd Floor Chicago IL 60606	No	No	No	No
1813487	Thoma Bravo Ugp, Llc	C/O Thoma Bravo, L.p. 110 N. Wacker Drive, 32Nd Floor Chicago IL 60606	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-11-15	10,000,000	$50.00	31,857,273	No	4	S	Indirect	See footnote
Common Stock	Disposition	2023-11-15	2,576,137	$0.00	31,857,273	No	4	J	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	J	Indirect	See footnote

Footnotes

After giving effect to the distribution reported on this statement, consists of 3,239,632 shares held directly by Thoma Bravo Fund X, L.P. ("TB Fund X"), 694,491 shares held directly by Thoma Bravo Fund X-A, L.P. ("TB Fund X-A"), 15,250,396 shares held directly by Thoma Bravo Fund XI, L.P. ("TB Fund XI"), 7,482,290 shares held directly by Thoma Bravo Fund XI-A, L.P. ("TB Fund XI-A"), 329,933 shares held directly by Thoma Bravo Executive Fund XI, L.P. ("TB Exec Fund"), 273,513 shares held directly by Thoma Bravo Special Opportunities Fund I, L.P. ("TB SOF"), 2,010,881 shares held directly by Thoma Bravo Special Opportunities Fund I AIV, L.P. ("TB SOF AIV"), 545,546 shares held directly by Thoma Bravo Partners X, L.P. ("TB Partners X"), and 2,030,591 shares held directly by Thoma Bravo Partners XI, L.P. ("TB Partners XI").
TB Partners X is the general partner of each of TB Fund X, TB Fund X-A, TB SOF and TB SOF AIV. TB Partners XI is the general partner of each of TB Fund XI, TB Fund XI-A and TB Exec Fund. Thoma Bravo UGP, LLC is the ultimate managing member of TB Partners X and TB Partners XI. By virtue of the relationships described in this footnote, Thoma Bravo UGP, LLC may be deemed to exercise voting and dispositive power with respect to the shares held by TB Fund X, TB Fund X-A, TB SOF, TB SOF AIV, TB Fund XI, TB Fund XI-A, TB Exec Fund, TB Partners X and TB Partners XI. Each of TB Partners X, TB Partners XI and Thoma Bravo UGP, LLC disclaims beneficial ownership of the shares owned by TB Fund X, TB Fund X-A, TB SOF, TB SOF AIV, TB Fund XI, TB Fund XI-A and TB Exec Fund except to the extent of its pecuniary interest therein.
Represents a distribution of (i) 159,600 shares held directly by TB SOF AIV, 22,217 shares held directly by TB SOF, 309,847 shares held directly by TB Fund X and 53,882 shares held directly by TB Fund X-A, in each case to TB Partners X, and (ii) 25,609 shares held directly by TB Exec Fund, 1,450,201 shares held directly by TB Fund XI, and 554,781 shares held directly by TB Fund XI-A, in each case to TB Partners XI.